SELP and coronary artery disorder: Compared with the non-diabetic CHD group, the expression levels of CD62p (1.03%±0.83% vs. 1.86%±1.71%, P<0.001, Figure 1A) and PAC-1 (0.89%±1.31% vs. 1.97%±3.33%, P<0.01, Figure 1B) on the platelet surface, as well as the proportions of PLA (13.98%±4.24% vs. 16.91%±4.59%, P<0.001), PNA (13.12%±4.16% vs. 15.99%±4.53%, P<0.001), PLyA (14.41%±3.99% vs. 16.85%±4.21%, P<0.001), and PMA (15.15%±5.17% vs. 19.65%±5.92%, P<0.001, Figure 1C) were significantly higher in the diabetic CHD group, which indicated higher platelet activation in the diabetic CHD group compared with the non-diabetic CHD group.